The Middle East Respiratory Syndrome (MERS)
- PMID: 31668197
- PMCID: PMC7127753
- DOI: 10.1016/j.idc.2019.08.001
The Middle East Respiratory Syndrome (MERS)
Abstract
The Middle East respiratory syndrome (MERS) is a novel lethal zoonotic disease of humans caused by the MERS coronavirus (MERS-CoV). Although MERS is endemic to the Middle East, travelers have exported MERS-CoV on return to their home countries. Clinical manifestations range from mild to severe acute respiratory disease and death. The elderly, immunocompromised, and those with chronic comorbid liver, lung, and hepatic conditions have a high mortality rate. There is no specific treatment. Person-to-person spread causes hospital and household outbreaks, and thus improved compliance with internationally recommended infection control protocols and rapid implementation of infection control measures are required.
Keywords: Epidemiology diagnosis; MERS-CoV; Middle East respiratory syndrome coronavirus; Treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures
References
-
- WHO Middle East respiratory syndrome coronavirus (MERS-CoV) 2019. https://www.who.int/emergencies/mers-cov/en/ Available at: Accessed June 1, 2019.
-
- Zaki A.M., van Boheemen S., Bestebroer T.M., et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
-
- WHO List of priority Blueprint diseases. https://www.who.int/blueprint/priority-diseases/en/ Available at: Accessed January 20, 2019.
